Millennium Management
BVS icon

Millennium Management’s Bioventus BVS Stock Holding History

Millennium Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$669K – 6028
2025
Q3 		$669K Buy
+100,000
New +$694K ﹤0.01% 4895
2022
Q1 		– Sell
-50,000
Closed -$725K – 6935
2021
Q4 		$725K Buy
+50,000
New +$711K ﹤0.01% 4723

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management's BVS Position: Q1 2026 in Review

Millennium Management reduced its Bioventus (BVS) stake by 72% in Q1 2026, selling an estimated $359K and leaving 16,633 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #5254.

Millennium Management first reported a position in BVS in Q1 2021 and has held it in 20 quarters since. The position peaked at $33M in Q1 2021. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Millennium Management held 16,633 shares of Bioventus worth $152K as of Q1 2026.
  • Millennium Management sold 42,789 Bioventus shares in Q1 2026, an estimated $359K.
  • Bioventus made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5254 holding.
  • Millennium Management first reported a position in Bioventus in Q1 2021 and has held it in 20 quarters since.
  • Millennium Management's Bioventus position peaked at $33M in Q1 2021.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.